Daniel Goodman

Daniel Winter Goodman is the founder of Resolvyx Pharmaceuticals, Inc. (founded in 2001), Psychogenics, Inc. (founded in 1998), Riverside Pharmaceuticals Corp.
(founded in 2012), The Midtown Practice For Psychotherapy & Psychiatry (founded in 2017), and Daniel Goodman MD PC (founded in 2003).
He holds the title of President at Resolvyx Pharmaceuticals, Inc., Director at Psychogenics, Inc., Chief Executive Officer at Riverside Pharmaceuticals Corp., President at The Midtown Practice For Psychotherapy & Psychiatry, and President at Daniel Goodman MD PC.
Currently, Dr. Goodman is an Assistant Professor at Weill Cornell Medical College.
He previously worked as an Independent Director at Tonix Pharmaceuticals Holding Corp.
from 2019 to 2022.
Dr. Goodman obtained a doctorate degree from Harvard Medical School, an MBA degree from Columbia Business School, and an undergraduate degree from Yale College.